NewLimit

NewLimit is a biotechnology company working to radically extend human healthspan.

We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells. We leverage functional genomics, pooled perturbation screening, and machine learning models to unravel the biology of epigenetic aging and disease using experiments of unprecedented scale.

Current Job Openings

Metabolism

Group Leader, Metabolism
South San Francisco

Operations

Head of Operations
South San Francisco, CA

Predictive Modeling

Machine Learning Scientist
South San Francisco, CA

Single Cell Technology